Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
SNDX on Nasdaq
Keith A. Goldan - trading volume in the past year for Syndax Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Stock Options (Right to buy) |
70K |
$1.56M |
$22.28 |
Feb 7, 2024 |
Direct |
Common Stock |
|
| Common Stock |
52.6K |
$1.05M |
$20.03 |
Jun 14, 2024 |
Direct |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.